Parsing the death toll of COPD

October 2010
Clinical Oncology Alert;Oct2010 Supplement, p19
No abstract available.


Related Articles

  • Parsing the death toll of COPD. Kuritzky, Louis // Clinical Cardiology Alert;Oct2010 Pharmacology, p19 

    The article discusses research study on mortality rate of chronic obstructive pulmonary disease (COPD), which references a study by B. Zvezdin et el, published in a 2009 issue of "Chest."

  • Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Mcgarvey, Lorcan P.; John, Matthias; Anderson, Julie A.; Zvarich, Michael; Wise, Robert A. // Thorax;May2007, Vol. 62 Issue 5, p411 

    Background: TORCH (Towards a Revolution in COPD Health) is an international multicentre, randomised, placebo-controlled clinical trial of inhaled fluticasone propionate/salmeterol combination treatment and its monotherapy components for maintenance treatment of moderately to severely impaired...

  • Analiza zgonów z powodu obturacyjnych chorób pÅ‚uc w województwie pomorskim w latach 2001-2008. ROMANTOWSKI, JAN; MACHUT, AGNIESZKA; JASSEM, EWA; CHEŁMIŃSKA, MARTA; NIEDOSZYTKO, MAREK // Alergia Astma Immunologia;cze2012, Vol. 17 Issue 2, p103 

    Introduction. Pulmonary obstructive diseases are considered as an increasing public health issue in the majority of developed countries. The research is an analysis of deaths caused by COPD and asthma in Pomerania region in 2001-2008. Aim. Assessment of structure and changes in deaths caused by...

  • Chronic Obstructive Pulmonary Disease.  // South Dakota Medicine;2009 Supplement, p30 

    Chronic obstructive pulmonary disease (COPD) is the fourth-leading cause of death in the United States, and the mortality rate continues to rise. Cigarette smoking is the major cause. COPD is preventable and treatable. Early recognition is important to decrease morbidity and mortality.

  • Assessing the impact of health policies on COPD. Berjon-Aparicio, Sonia // British Journal of Community Nursing;Jun2007, Vol. 12 Issue 6, p253 

    COPD is a leading but under-recognized cause of morbidity and mortality worldwide. It is currently the fourth leading cause of death in the world, and the fifth commonest cause of death in England and Wales, accounting for nearly 28,000 deaths each year. Methods: The author analyses...

  • Deaths from chronic obstructive pulmonary disease in France, 1979-2002: a multiple cause analysis. Fuhrman, C.; Jougla, E.; Nicolau, J.; Eilstein, D.; Delmas, M-C. // Thorax;Nov2006, Vol. 61 Issue 11, p930 

    Background: A study was undertaken of deaths with an underlying or associated cause of chronic obstructive pulmonary disease (COPD), and trends in COPD mortality from 1979 to 2002 in France were analysed. Methods: Data were obtained from the Centre of Epidemiology on the Medical Causes of Death...

  • Cause of death changing for patients with COPD.  // British Journal of Hospital Medicine (17508460);Feb2011, Vol. 72 Issue 2, p68 

    The article reports a study by researchers in Sweden (Magnus Ekström and colleagues), which indicated that chronic obstructive pulmonary disease (COPD) patients on long-term oxygen therapy face an increased risk of death from cardiovascular disease and other non-respiratory ailments.

  • Combined effect of lung function level and decline increases morbidity and mortality risks. Baughman, Penelope; Marott, Jacob; Lange, Peter; Martin, Christopher; Shankar, Anoop; Petsonk, Edward; Hnizdo, Eva // European Journal of Epidemiology;Dec2012, Vol. 27 Issue 12, p933 

    Lung function level and decline are each predictive of morbidity and mortality. Evaluation of the combined effect of these measurements may help further identify high-risk groups. Using Copenhagen City Heart Study longitudinal spirometry data (n = 10,457), 16-21 year risks of chronic obstructive...

  • COPD Patients on LTOT At Risk For Non-Lung Disease Mortality Over Time. Marshall, Adriene // Pulmonary Reviews;Mar2011, Vol. 16 Issue 3, p1 

    The article reports on the increased risk of death from non-respiratory ailments facing chronic obstructive pulmonary disease (COPD) patients on long-term oxygen therapy (LTOT). Based on a Swedish study, it would appear that such patients have a progressively higher burden of comorbidity and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics